Wikidata

(Q53239126)

English

A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer's disease.

scientific article published in January 2000

  • A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer's disease
In more languages

Statements

title
A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer's disease. (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
11096224
retrieved
12 May 2018
reference URL
http://europepmc.org/abstract/MED/11096224
main subject
patient
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q53239126&oldid=1767374845"